Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +54.01%
#3 Glidr Glidr +40.55%
#4 Cysic Cysic +38.33%
#5 Walrus Walrus +31.36%
#6 Humanity Humanity +26.19%
#7 Enso Enso +16.12%
#8 Tutorial Tutorial +16.11%
#9 Velvet Velvet +15.00%
#10 Codatta Codatta +14.84%
Coin of the day
EXOD EXOD
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
DermTech, Inc. DermTech, Inc.

DermTech, Inc.

DMTK
Peringkat dalam Saham #37065
DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla,... DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla, California, specializes in creating and bringing to market advanced, non-invasive genomic tests. Operating within the United States, their innovative solutions facilitate the diagnosis of various dermatological issues, including skin cancer, inflammatory conditions, and age-related skin concerns. A cornerstone of their offerings is the DermTech Melanoma Test (DMT), a sophisticated gene expression analysis. This assay plays a crucial role in enhancing the early identification of genomic abnormalities, effectively aiding in the exclusion of melanoma and often removing the need for invasive surgical biopsies of suspicious pigmented lesions. The company further provides specialized adhesive kits for convenient skin sample collection. Additionally, they offer gene expression assays designed to analyze key inflammatory pathways such, as Th1, Th2, IFN-gamma, and Th17. Looking ahead, DermTech is actively developing a pipeline of new products, which includes DNA risk assessment tools for UV damage, diagnostic tests for non-melanoma skin cancers, and rule-out tests for cutaneous T-cell lymphoma. They also extend their services by delivering health-related information and support through digital and telecommunication platforms. DermTech's diagnostic products and services are primarily targeted towards medical professionals in the fields of pathology and oncology.
Harga Saham
$0.069
Terakhir disinkronkan: 2024-07-22
Kapitalisasi Pasar
$2.06M
Perubahan (1 hari)
-1.43%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan DermTech, Inc. (DMTK)

Kategori

Healthcare
Pendapatan untuk DermTech, Inc. (DMTK)
Pendapatan pada Mar 2024 TTM: $15.66M
Menurut laporan keuangan terbaru dari DermTech, Inc., pendapatan saat ini (TTM) adalah $15.66M. Pada tahun 2022, perusahaan menghasilkan pendapatan sebesar $14.52M peningkatan dibandingkan pendapatan pada tahun 2021 yang sebesar $11.84M. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan DermTech, Inc. dari 2012 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Mengubah
2026 (TTM) $15.66M 2.41%
2023 $15.30M 5.36%
2022 $14.52M 22.64%
2021 $11.84M 101.16%
2020 $5.89M 74.94%
2019 $3.36M 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2013 0.00 0.00%
2012 0.00 0.00%
Pendapatan untuk perusahaan serupa atau pesaing
Perusahaan Pendapatan Perbedaan Pendapatan Negara
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $46.34B 295,712.05%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $25.11B 160,184.73%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $2.71B 17,182.16%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 $4.55B 28,968.07%
US